JPH11510488A5 - - Google Patents
Info
- Publication number
- JPH11510488A5 JPH11510488A5 JP1997506919A JP50691997A JPH11510488A5 JP H11510488 A5 JPH11510488 A5 JP H11510488A5 JP 1997506919 A JP1997506919 A JP 1997506919A JP 50691997 A JP50691997 A JP 50691997A JP H11510488 A5 JPH11510488 A5 JP H11510488A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/505,606 US5925351A (en) | 1995-07-21 | 1995-07-21 | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| US08/505,606 | 1995-07-21 | ||
| PCT/US1996/012010 WO1997003687A1 (en) | 1995-07-21 | 1996-07-19 | SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007161925A Division JP2007254488A (ja) | 1995-07-21 | 2007-06-19 | 免疫学的疾患の処置のための治療剤としての可溶性リンホトキシン−βレセプターならびに抗リンホトキシンレセプターおよびリガンド抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11510488A JPH11510488A (ja) | 1999-09-14 |
| JPH11510488A5 true JPH11510488A5 (enExample) | 2004-08-26 |
| JP4174563B2 JP4174563B2 (ja) | 2008-11-05 |
Family
ID=24011046
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50691997A Expired - Fee Related JP4174563B2 (ja) | 1995-07-21 | 1996-07-19 | 免疫学的疾患の処置のための治療剤としての可溶性リンホトキシン−βレセプターならびに抗リンホトキシンレセプターおよびリガンド抗体 |
| JP2007161925A Withdrawn JP2007254488A (ja) | 1995-07-21 | 2007-06-19 | 免疫学的疾患の処置のための治療剤としての可溶性リンホトキシン−βレセプターならびに抗リンホトキシンレセプターおよびリガンド抗体 |
| JP2011209921A Withdrawn JP2012041350A (ja) | 1995-07-21 | 2011-09-26 | 免疫学的疾患の処置のための治療剤としての可溶性リンホトキシン−βレセプターならびに抗リンホトキシンレセプターおよびリガンド抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007161925A Withdrawn JP2007254488A (ja) | 1995-07-21 | 2007-06-19 | 免疫学的疾患の処置のための治療剤としての可溶性リンホトキシン−βレセプターならびに抗リンホトキシンレセプターおよびリガンド抗体 |
| JP2011209921A Withdrawn JP2012041350A (ja) | 1995-07-21 | 2011-09-26 | 免疫学的疾患の処置のための治療剤としての可溶性リンホトキシン−βレセプターならびに抗リンホトキシンレセプターおよびリガンド抗体 |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US5925351A (enExample) |
| EP (2) | EP1488799A3 (enExample) |
| JP (3) | JP4174563B2 (enExample) |
| KR (2) | KR100493980B1 (enExample) |
| CN (3) | CN1607005A (enExample) |
| AT (1) | ATE279205T1 (enExample) |
| AU (1) | AU715407B2 (enExample) |
| BG (1) | BG63330B1 (enExample) |
| BR (1) | BR9609716A (enExample) |
| CA (1) | CA2227477A1 (enExample) |
| CZ (1) | CZ298277B6 (enExample) |
| DE (1) | DE69633624T2 (enExample) |
| DK (1) | DK0840616T3 (enExample) |
| EA (3) | EA005734B1 (enExample) |
| EE (1) | EE04419B1 (enExample) |
| ES (1) | ES2225889T3 (enExample) |
| FI (1) | FI980122L (enExample) |
| HU (1) | HU227508B1 (enExample) |
| MX (1) | MX9800624A (enExample) |
| NO (2) | NO327163B1 (enExample) |
| NZ (2) | NZ503818A (enExample) |
| PL (1) | PL186911B1 (enExample) |
| PT (1) | PT840616E (enExample) |
| RO (1) | RO121799B1 (enExample) |
| SI (1) | SI0840616T1 (enExample) |
| SK (1) | SK286409B6 (enExample) |
| TR (1) | TR199800091T1 (enExample) |
| WO (1) | WO1997003687A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925351A (en) * | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| US7255854B1 (en) * | 1996-10-25 | 2007-08-14 | Biogen, Inc. | Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| DE69736244T2 (de) * | 1996-10-25 | 2007-05-31 | Biogen Idec Ma Inc., Cambridge | Lösliche lymphotoxin-beta rezeptoren, anti-lymphotoxin-antikörper und anti-lymphotoxin ligand antikörper als therapeutische wirkstoffe zur behandlung von immunologischen krankheiten |
| SI0954333T1 (sl) * | 1996-10-25 | 2006-12-31 | Biogen Idec Inc | Topni limfotoksin-beta receptorji, anti-limfotoksin receptorska protitelesa in anti-limfotoksin ligandna protitelesa kot terapevtska sredstva za zdravljenje imunoloskih bolezni |
| DE69838061T2 (de) * | 1997-04-18 | 2008-03-13 | Biogen Idec Ma Inc., Cambridge | Typ ii tgf-beta receptor/immunoglobulin konstante domäne fusionsproteine |
| US7118742B2 (en) * | 1997-07-07 | 2006-10-10 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
| US7060667B1 (en) * | 1998-01-30 | 2006-06-13 | Biogen Idec Ma, Inc. | Treatment of follicular lymphomas using inhibitors of the LT pathway |
| PT1051187E (pt) * | 1998-01-30 | 2004-03-31 | Biogen Inc | Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt) |
| EA006703B1 (ru) * | 1998-10-09 | 2006-02-24 | Байоджен Айдек Эмэй Инк. | СПОСОБ ЛЕЧЕНИЯ ИНДИВИДУУМА, СТРАДАЮЩЕГО ОТ ВЫЗВАННОГО ВИРУСОМ СИСТЕМНОГО ШОКА И/ИЛИ РАССТРОЙСТВА ДЫХАНИЯ, И СПОСОБ ИНДУЦИРОВАНИЯ ПРОТИВОВИРУСНОГО ОТВЕТА У ДАННОГО ИНДИВИДУУМА ПУТЕМ БЛОКАДЫ ПУТИ МЕТАБОЛИЗМА ЛИМФОТОКСИНА-β |
| TR200504220T2 (tr) * | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
| BR0012006A (pt) * | 1999-06-28 | 2002-03-12 | Basf Ag | Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr |
| US6346247B1 (en) | 1999-10-28 | 2002-02-12 | Promega Corporation | Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| HUP0302573A2 (hu) * | 2000-10-13 | 2003-10-28 | Biogen, Inc. | Humanizált anti-LT-béta-R ellenanyagok |
| PT1355942E (pt) * | 2000-12-07 | 2008-11-21 | Lilly Co Eli | Proteínas de fusão de glp-1 |
| WO2002083162A1 (en) * | 2001-04-13 | 2002-10-24 | University Of Chicago | Use of a cd8+ t cell inhibitory agent in the presence of a cd4+ t cell inhibitory agent for inhibition of transplant rejection |
| US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| WO2003011322A1 (en) * | 2001-08-02 | 2003-02-13 | Genset S.A. | Agonists and antagonists of genoxin for use in the treatment of metabolic disorders |
| US7273707B2 (en) * | 2002-02-08 | 2007-09-25 | Wyeth | Method of identifying a modulator of a LTβR complex signaling pathway |
| CA2491480A1 (en) * | 2002-07-01 | 2004-01-08 | Biogen, Inc. | Humanized anti-lymphotoxin beta receptor antibodies |
| AU2003287431A1 (en) * | 2002-10-31 | 2004-05-25 | Biogen Idec Ma Inc. | Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| JP2006513225A (ja) * | 2002-12-20 | 2006-04-20 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 化学療法剤と組み合わせたリンホトキシンβ受容体因子 |
| CA2511013A1 (en) * | 2002-12-20 | 2004-07-15 | Biogen Idec Ma Inc. | Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| NZ544924A (en) * | 2003-06-27 | 2009-03-31 | Biogen Idec Inc | Modified binding molecules comprising connecting peptides |
| EP1699486A4 (en) * | 2003-12-08 | 2007-07-18 | Centocor Inc | ANTI-LYMPHOTOXIN HUMAN ALPHA ANTIBODIES, COMPOSITIONS, METHODS AND USES |
| CN1980957A (zh) * | 2004-03-23 | 2007-06-13 | 比奥根艾迪克Ma公司 | 受体偶联剂及其治疗用途 |
| JP2008509153A (ja) * | 2004-08-03 | 2008-03-27 | バイオレクシス ファーマシューティカル コーポレイション | Ｇｌｐ−１を含むトランスフェリン融合タンパク質用いた併用療法 |
| WO2006074399A2 (en) * | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| WO2006135660A2 (en) * | 2005-06-10 | 2006-12-21 | University Of Chicago | Therapies involving lymphotoxin beta receptor |
| EP1942936A2 (en) * | 2005-10-04 | 2008-07-16 | The Johns Hopkins University | Compositions and methods for treating inflammation |
| WO2007109733A2 (en) | 2006-03-21 | 2007-09-27 | The Johns Hopkins University | Diagnostic and prognostic markers and treatment strategies for multiple sclerosis |
| JP5102833B2 (ja) * | 2006-07-24 | 2012-12-19 | バイオレクシス ファーマシューティカル コーポレーション | エキセンディン融合タンパク質 |
| WO2008063776A2 (en) | 2006-10-12 | 2008-05-29 | Genentech, Inc. | Antibodies to lymphotoxin-alpha |
| NZ576424A (en) | 2006-10-20 | 2012-09-28 | Biogen Idec Inc | Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| US8338376B2 (en) * | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| KR101581961B1 (ko) | 2006-11-02 | 2016-01-04 | 악셀레론 파마 인코포레이티드 | Ａｌｋ１ 수용체 및 리간드 길항제 및 그의 용도 |
| US8440185B2 (en) | 2006-12-26 | 2013-05-14 | The Johns Hopkins University | Compositions and methods for the treatment of immunologic disorders |
| EP2139509A2 (en) * | 2007-03-15 | 2010-01-06 | Biogen Idec MA, Inc. | Treatment of autoimmune disorders |
| AU2008261869B2 (en) | 2007-06-08 | 2014-12-18 | Biogen Ma Inc. | Biomarkers for predicting anti-TNF responsiveness or non-responsiveness |
| CA2748757A1 (en) * | 2008-12-31 | 2010-07-08 | Biogen Idec Ma Inc. | Anti-lymphotoxin antibodies |
| KR20180033499A (ko) | 2015-06-05 | 2018-04-03 | 아이바이오, 인크. | 섬유증을 치료하는데 사용하기 위한 엔도스타틴 단편 및 변이체 |
| US12448458B2 (en) * | 2018-06-15 | 2025-10-21 | Universität Bern | Ligands to light or its receptor LTßR for use in haematologic malignancies |
| EP3969569A1 (en) | 2019-05-14 | 2022-03-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Regulatory t cells targeted by lymphotoxin alpha blocking agent and uses thereof |
| WO2023028451A2 (en) | 2021-08-25 | 2023-03-02 | Ibio, Inc. | Anti-cd-25 antibody |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US4758549A (en) | 1983-12-13 | 1988-07-19 | Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo | Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses |
| US4959457A (en) * | 1984-05-31 | 1990-09-25 | Genentech, Inc. | Anti-lymphotoxin |
| NZ212207A (en) * | 1984-05-31 | 1991-07-26 | Genentech Inc | Recombinant lymphotoxin |
| GB8529014D0 (en) | 1985-11-25 | 1986-01-02 | Biogen Nv | Enhanced secretion of heterologous proteins |
| US4822605A (en) | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
| US4849509A (en) | 1987-02-20 | 1989-07-18 | The Wistar Institute | Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies |
| CA2001756A1 (en) | 1988-10-31 | 1991-04-30 | Seiichi Uesugi | New human lymphotoxin n-end deletion mutant |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| ES2157889T3 (es) | 1990-06-27 | 2001-09-01 | Biogen Inc | Linfotoxina complejada de superficie. |
| US7030080B2 (en) | 1990-06-27 | 2006-04-18 | Biogen, Inc. | Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| US5670149A (en) | 1990-06-27 | 1997-09-23 | Biogen, Inc. | Lymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| WO1994013808A2 (en) * | 1992-12-04 | 1994-06-23 | Biogen, Inc. | LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5747023A (en) | 1994-07-01 | 1998-05-05 | Genentech, Inc. | Cancer therapy using lymphotoxin |
| US5876950A (en) | 1995-01-26 | 1999-03-02 | Bristol-Myers Squibb Company | Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy |
| US6312691B1 (en) | 1996-01-26 | 2001-11-06 | Jeffrey L. Browning | Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents |
| CN1900116A (zh) | 1995-01-26 | 2007-01-24 | 拜奥根Idec马萨诸塞公司 | 抗－LT－β－R抗体、含有该抗体的药用组合物及其制药应用 |
| GB9514518D0 (en) | 1995-07-15 | 1995-09-13 | Sod Conseils Rech Applic | Guanidine salt inhibitors of NO synthase and cyclooxygenase |
| US5925351A (en) * | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| US6291207B1 (en) | 1995-07-28 | 2001-09-18 | Northwestern University | Herpes virus entry receptor protein |
| DE69736244T2 (de) | 1996-10-25 | 2007-05-31 | Biogen Idec Ma Inc., Cambridge | Lösliche lymphotoxin-beta rezeptoren, anti-lymphotoxin-antikörper und anti-lymphotoxin ligand antikörper als therapeutische wirkstoffe zur behandlung von immunologischen krankheiten |
| US7255854B1 (en) | 1996-10-25 | 2007-08-14 | Biogen, Inc. | Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| GB9622660D0 (en) | 1996-10-31 | 1997-01-08 | Biocine Spa | Immunogenic detoxified mutant toxin |
| CA2229449A1 (en) | 1997-04-25 | 1998-10-25 | Takeda Chemical Industries, Ltd. | Novel receptor protein and its use |
| US7060667B1 (en) | 1998-01-30 | 2006-06-13 | Biogen Idec Ma, Inc. | Treatment of follicular lymphomas using inhibitors of the LT pathway |
| EA006703B1 (ru) * | 1998-10-09 | 2006-02-24 | Байоджен Айдек Эмэй Инк. | СПОСОБ ЛЕЧЕНИЯ ИНДИВИДУУМА, СТРАДАЮЩЕГО ОТ ВЫЗВАННОГО ВИРУСОМ СИСТЕМНОГО ШОКА И/ИЛИ РАССТРОЙСТВА ДЫХАНИЯ, И СПОСОБ ИНДУЦИРОВАНИЯ ПРОТИВОВИРУСНОГО ОТВЕТА У ДАННОГО ИНДИВИДУУМА ПУТЕМ БЛОКАДЫ ПУТИ МЕТАБОЛИЗМА ЛИМФОТОКСИНА-β |
| TR200504220T2 (tr) | 1998-12-17 | 2007-04-24 | Biogen Idec Ma Inc. | Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem. |
| HUP0302573A2 (hu) | 2000-10-13 | 2003-10-28 | Biogen, Inc. | Humanizált anti-LT-béta-R ellenanyagok |
| CA2491480A1 (en) | 2002-07-01 | 2004-01-08 | Biogen, Inc. | Humanized anti-lymphotoxin beta receptor antibodies |
| CA2511013A1 (en) | 2002-12-20 | 2004-07-15 | Biogen Idec Ma Inc. | Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| JP2006513225A (ja) | 2002-12-20 | 2006-04-20 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 化学療法剤と組み合わせたリンホトキシンβ受容体因子 |
| CN1980957A (zh) | 2004-03-23 | 2007-06-13 | 比奥根艾迪克Ma公司 | 受体偶联剂及其治疗用途 |
| CA2655411A1 (en) | 2006-06-15 | 2007-12-21 | Biogen Idec Ma Inc. | Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents |
-
1995
- 1995-07-21 US US08/505,606 patent/US5925351A/en not_active Expired - Lifetime
-
1996
- 1996-07-19 AU AU65912/96A patent/AU715407B2/en not_active Ceased
- 1996-07-19 CN CNA200410007059XA patent/CN1607005A/zh active Pending
- 1996-07-19 DE DE69633624T patent/DE69633624T2/de not_active Expired - Lifetime
- 1996-07-19 SK SK68-98A patent/SK286409B6/sk not_active IP Right Cessation
- 1996-07-19 CA CA002227477A patent/CA2227477A1/en not_active Abandoned
- 1996-07-19 JP JP50691997A patent/JP4174563B2/ja not_active Expired - Fee Related
- 1996-07-19 HU HU9802483A patent/HU227508B1/hu not_active IP Right Cessation
- 1996-07-19 MX MX9800624A patent/MX9800624A/es not_active IP Right Cessation
- 1996-07-19 EA EA200200503A patent/EA005734B1/ru not_active IP Right Cessation
- 1996-07-19 KR KR10-1998-0700464A patent/KR100493980B1/ko not_active Expired - Fee Related
- 1996-07-19 EE EE9800013A patent/EE04419B1/xx not_active IP Right Cessation
- 1996-07-19 KR KR1020047017609A patent/KR100557258B1/ko not_active Expired - Fee Related
- 1996-07-19 DK DK96925393T patent/DK0840616T3/da active
- 1996-07-19 CN CNA2006101002067A patent/CN1895670A/zh active Pending
- 1996-07-19 SI SI9630693T patent/SI0840616T1/xx unknown
- 1996-07-19 US US09/000,166 patent/US6403087B1/en not_active Expired - Lifetime
- 1996-07-19 FI FI980122A patent/FI980122L/fi not_active IP Right Cessation
- 1996-07-19 TR TR1998/00091T patent/TR199800091T1/xx unknown
- 1996-07-19 ES ES96925393T patent/ES2225889T3/es not_active Expired - Lifetime
- 1996-07-19 EP EP04017208A patent/EP1488799A3/en not_active Withdrawn
- 1996-07-19 AT AT96925393T patent/ATE279205T1/de active
- 1996-07-19 PL PL96324622A patent/PL186911B1/pl not_active IP Right Cessation
- 1996-07-19 EP EP96925393A patent/EP0840616B1/en not_active Expired - Lifetime
- 1996-07-19 EA EA200000122A patent/EA002966B1/ru not_active IP Right Cessation
- 1996-07-19 BR BR9609716A patent/BR9609716A/pt active Search and Examination
- 1996-07-19 PT PT96925393T patent/PT840616E/pt unknown
- 1996-07-19 CZ CZ0017298A patent/CZ298277B6/cs not_active IP Right Cessation
- 1996-07-19 NZ NZ503818A patent/NZ503818A/en not_active IP Right Cessation
- 1996-07-19 NZ NZ313441A patent/NZ313441A/en not_active IP Right Cessation
- 1996-07-19 RO RO98-00101A patent/RO121799B1/ro unknown
- 1996-07-19 CN CNB961967706A patent/CN1146441C/zh not_active Expired - Fee Related
- 1996-07-19 EA EA199800144A patent/EA001200B1/ru not_active IP Right Cessation
- 1996-07-19 WO PCT/US1996/012010 patent/WO1997003687A1/en not_active Ceased
-
1998
- 1998-01-14 NO NO19980172A patent/NO327163B1/no not_active IP Right Cessation
- 1998-02-20 BG BG102265A patent/BG63330B1/bg unknown
-
1999
- 1999-04-30 US US09/303,262 patent/US6669941B1/en not_active Expired - Lifetime
-
2002
- 2002-02-15 US US10/077,406 patent/US7427403B2/en not_active Expired - Fee Related
-
2007
- 2007-06-19 JP JP2007161925A patent/JP2007254488A/ja not_active Withdrawn
- 2007-10-31 US US11/982,415 patent/US7951371B2/en not_active Expired - Fee Related
-
2008
- 2008-09-05 NO NO20083842A patent/NO20083842L/no not_active Application Discontinuation
-
2011
- 2011-02-28 US US13/037,092 patent/US8455445B2/en not_active Expired - Fee Related
- 2011-09-26 JP JP2011209921A patent/JP2012041350A/ja not_active Withdrawn